{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T13:13:11Z","timestamp":1788873191806,"version":"build-2803163510"},"reference-count":45,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,12,27]],"date-time":"2022-12-27T00:00:00Z","timestamp":1672099200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82170793"],"award-info":[{"award-number":["82170793"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"publisher","award":["2021YFC2500202"],"award-info":[{"award-number":["2021YFC2500202"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Immunopharmacology"],"published-print":{"date-parts":[[2023,2]]},"DOI":"10.1016\/j.intimp.2022.109656","type":"journal-article","created":{"date-parts":[[2023,1,4]],"date-time":"2023-01-04T05:52:11Z","timestamp":1672811531000},"page":"109656","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"special_numbering":"C","title":["Minnelide combined with Angptl3 knockout completely protects mice with adriamycin nephropathy via suppression of TGF-\u03b21-Smad2 and p53 pathways"],"prefix":"10.1016","volume":"115","author":[{"given":"Baowei","family":"Ji","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junchao","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanli","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ye","family":"Yin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qian","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.intimp.2022.109656_b0005","doi-asserted-by":"crossref","first-page":"332","DOI":"10.2215\/CJN.05000516","article-title":"Minimal change disease","volume":"12","author":"Vivarelli","year":"2017","journal-title":"Clin. J. Am. Soc. Nephrol. CJASN"},{"issue":"4","key":"10.1016\/j.intimp.2022.109656_b0010","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1681\/ASN.2013030251","article-title":"Rituximab in steroid-dependent or frequently relapsing idiopathic nephrotic syndrome","volume":"25","author":"Ruggenenti","year":"2014","journal-title":"J. Am. Soc. Nephrol. JASN"},{"issue":"2","key":"10.1016\/j.intimp.2022.109656_b0015","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.jpeds.2005.03.050","article-title":"Children with steroid-sensitive nephrotic syndrome come of age: long-term outcome","volume":"147","author":"R\u00fcTH","year":"2005","journal-title":"J. pediatrics"},{"issue":"2","key":"10.1016\/j.intimp.2022.109656_b0020","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/S0022-3476(88)80260-9","article-title":"Corticosteroids and growth","volume":"113","author":"Hyams","year":"1988","journal-title":"J. pediatrics"},{"issue":"8","key":"10.1016\/j.intimp.2022.109656_b0025","doi-asserted-by":"crossref","first-page":"2397","DOI":"10.1093\/ndt\/gfq358","article-title":"Behavioural abnormalities in children with nephrotic syndrome\u2013an underappreciated complication of a standard treatment?","volume":"25","author":"Neuhaus","year":"2010","journal-title":"Nephrol. dialysis, transplantation : official publication of the Eur. Dialysis and Transplant Association \u2013 Eur. Renal Association"},{"issue":"4","key":"10.1016\/j.intimp.2022.109656_b0030","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1046\/j.1442-9071.2001.00426.x","article-title":"Ocular complications of paediatric patients with nephrotic syndrome","volume":"29","author":"Ng","year":"2001","journal-title":"Clin. Experiment. Ophthalmol."},{"issue":"10075","key":"10.1016\/j.intimp.2022.109656_b0035","doi-asserted-by":"crossref","first-page":"1238","DOI":"10.1016\/S0140-6736(16)32064-5","article-title":"Chronic Kidney Disease","volume":"389","author":"Webster","year":"2017","journal-title":"Lancet (London, England)"},{"issue":"14","key":"10.1016\/j.intimp.2022.109656_b0040","doi-asserted-by":"crossref","DOI":"10.3390\/ijms22147310","article-title":"Angiopoietin-Like Protein 3 (ANGPTL3) modulates lipoprotein metabolism and dyslipidemia","volume":"22","author":"Chen","year":"2021","journal-title":"Int. J. Mol. Sci."},{"issue":"2","key":"10.1016\/j.intimp.2022.109656_b0045","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1038\/ng814","article-title":"Angptl3 regulates lipid metabolism in mice","volume":"30","author":"Koishi","year":"2002","journal-title":"Nat. Genet."},{"issue":"2","key":"10.1016\/j.intimp.2022.109656_b0050","doi-asserted-by":"crossref","first-page":"2971","DOI":"10.1080\/21655979.2021.2024951","article-title":"Angiopoietin-like 3 (ANGPTL3) drives cell proliferation, migration and angiogenesis in cervical cancer via binding to integrin alpha v beta 3","volume":"13","author":"Zhong","year":"2022","journal-title":"Bioengineered"},{"issue":"19","key":"10.1016\/j.intimp.2022.109656_b0055","doi-asserted-by":"crossref","first-page":"17281","DOI":"10.1074\/jbc.M109768200","article-title":"ANGPTL3 stimulates endothelial cell adhesion and migration via integrin alpha vbeta 3 and induces blood vessel formation in vivo","volume":"277","author":"Camenisch","year":"2002","journal-title":"J. Biol. Chem."},{"issue":"5","key":"10.1016\/j.intimp.2022.109656_b0060","first-page":"286","article-title":"Expression of ANGPTL3 in children with primary nephrotic syndrome","volume":"22","author":"Rao","year":"2006","journal-title":"Chinese J. Catal."},{"key":"10.1016\/j.intimp.2022.109656_b0065","first-page":"37","article-title":"Expression of ANGPTL3 in kidney and its relationship to proteinuria and hyperlipidemia in Adriamycininduced nephrotic rats","volume":"04","author":"Wu","year":"2005","journal-title":"Chin. J. Nephrol."},{"issue":"38","key":"10.1016\/j.intimp.2022.109656_b0070","article-title":"A vital role for Angptl3 in the PAN-induced podocyte loss by affecting detachment and apoptosis in vitro","volume":"16","author":"Dai","year":"2015","journal-title":"BMC Nephrol."},{"issue":"3","key":"10.1016\/j.intimp.2022.109656_b0075","doi-asserted-by":"crossref","first-page":"e38","DOI":"10.1159\/000313829","article-title":"Expression of angiopoietin-like 3 associated with puromycin-induced podocyte damage","volume":"115","author":"Jia","year":"2010","journal-title":"Nephron Exp. Nephrol."},{"issue":"6","key":"10.1016\/j.intimp.2022.109656_b0080","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1038\/pr.2015.38","article-title":"A novel role of angiopoietin-like-3 associated with podocyte injury","volume":"77","author":"Liu","year":"2015","journal-title":"Pediatric research"},{"issue":"20","key":"10.1016\/j.intimp.2022.109656_b0085","doi-asserted-by":"crossref","first-page":"7194","DOI":"10.1021\/ja00775a078","article-title":"Triptolide and tripdiolide, novel antileukemic diterpenoid triepoxides from Tripterygium wilfordii","volume":"94","author":"Kupchan","year":"1972","journal-title":"J. Am. Chem. Soc."},{"issue":"5","key":"10.1016\/j.intimp.2022.109656_b0090","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1038\/ki.2008.203","article-title":"Triptolide protects podocytes from puromycin aminonucleoside induced injury in vivo and in vitro","volume":"74","author":"Zheng","year":"2008","journal-title":"Kidney Int."},{"issue":"11","key":"10.1016\/j.intimp.2022.109656_b0095","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1038\/ki.2010.41","article-title":"Triptolide reduces proteinuria in experimental membranous nephropathy and protects against C5b-9-induced podocyte injury in vitro","volume":"77","author":"Chen","year":"2010","journal-title":"Kidney Int."},{"issue":"4","key":"10.1016\/j.intimp.2022.109656_b0100","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1039\/D0NP00054J","article-title":"Triptolide: reflections on two decades of research and prospects for the future","volume":"38","author":"Tong","year":"2021","journal-title":"Nat. Prod. Rep."},{"issue":"5","key":"10.1016\/j.intimp.2022.109656_b0105","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/j.tips.2019.03.002","article-title":"Triptolide and Its Derivatives as Cancer Therapies","volume":"40","author":"Noel","year":"2019","journal-title":"Trends Pharmacol. Sci."},{"issue":"156","key":"10.1016\/j.intimp.2022.109656_b0110","doi-asserted-by":"crossref","first-page":"156ra39","DOI":"10.1126\/scitranslmed.3004334","article-title":"A preclinical evaluation of Minnelide as a therapeutic agent against pancreatic cancer","volume":"4","author":"Chugh","year":"2012","journal-title":"Sci. Transl. Med."},{"issue":"1","key":"10.1016\/j.intimp.2022.109656_b0115","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1186\/s40168-021-01157-z","article-title":"Polyamine metabolism links gut microbiota and testicular dysfunction","volume":"9","author":"Zhao","year":"2021","journal-title":"Microbiome"},{"issue":"1","key":"10.1016\/j.intimp.2022.109656_b0120","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1186\/s13020-021-00525-z","article-title":"Therapeutic potential of triptolide in autoimmune diseases and strategies to reduce its toxicity","volume":"16","author":"Cheng","year":"2021","journal-title":"Chin. Med."},{"issue":"1","key":"10.1016\/j.intimp.2022.109656_b0125","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3109\/01480541003774358","article-title":"Triptolide induces adverse effect on reproductive parameters of female Sprague-Dawley rats","volume":"34","author":"Liu","year":"2011","journal-title":"Drug Chem. Toxicol."},{"issue":"5","key":"10.1016\/j.intimp.2022.109656_b0130","doi-asserted-by":"crossref","DOI":"10.1172\/JCI143645","article-title":"Endoplasmic reticulum protein TXNDC5 promotes renal fibrosis by enforcing TGF-\u03b2 signaling in kidney fibroblasts","volume":"131","author":"Chen","year":"2021","journal-title":"J. Clin. Invest."},{"issue":"4","key":"10.1016\/j.intimp.2022.109656_b0135","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1042\/CS20120252","article-title":"Role of the TGF-\u03b2\/BMP-7\/Smad pathways in renal diseases","volume":"124","author":"Meng","year":"2013","journal-title":"Clin Sci (Lond)"},{"issue":"4","key":"10.1016\/j.intimp.2022.109656_b0140","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1016\/j.yjmcc.2010.10.033","article-title":"Transforming growth factor (TGF)-\u03b2 signaling in cardiac remodeling","volume":"51","author":"Dobaczewski","year":"2011","journal-title":"J. Mol. Cell. Cardiol."},{"issue":"11","key":"10.1016\/j.intimp.2022.109656_b0145","doi-asserted-by":"crossref","first-page":"1675","DOI":"10.1161\/CIRCRESAHA.110.217737","article-title":"Potential therapeutic targets for cardiac fibrosis: TGFbeta, angiotensin, endothelin, CCN2, and PDGF, partners in fibroblast activation","volume":"106","author":"Leask","year":"2010","journal-title":"Circ. Res."},{"issue":"1","key":"10.1016\/j.intimp.2022.109656_b0150","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1111\/j.1440-1797.2010.01383.x","article-title":"Adriamycin nephropathy: a model of focal segmental glomerulosclerosis","volume":"16","author":"Lee","year":"2011","journal-title":"Nephrol. (Carlton)"},{"key":"10.1016\/j.intimp.2022.109656_b0155","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/j.carbpol.2018.06.109","article-title":"Preparation and renoprotective effects of carboxymethyl chitosan oligosaccharide on adriamycin nephropathy [J]","volume":"201","author":"Qiao","year":"2018","journal-title":"Carbohydr. Polym."},{"key":"10.1016\/j.intimp.2022.109656_b0160","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.pharmthera.2018.10.013","article-title":"P53 in kidney injury and repair: Mechanism and therapeutic potentials [J]","volume":"195","author":"Tang","year":"2019","journal-title":"Pharmacol Ther"},{"issue":"6","key":"10.1016\/j.intimp.2022.109656_b0165","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1016\/j.kint.2016.01.012","article-title":"Podocyte injury and its consequences","volume":"89","author":"Nagata","year":"2016","journal-title":"Kidney Int."},{"key":"10.1016\/j.intimp.2022.109656_b0170","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/S0065-230X(01)82002-9","article-title":"p53-dependent apoptosis pathways [J]","volume":"82","author":"Shen","year":"2001","journal-title":"Adv Cancer Res"},{"issue":"3","key":"10.1016\/j.intimp.2022.109656_b0175","doi-asserted-by":"crossref","first-page":"167","DOI":"10.5483\/BMBRep.2014.47.3.261","article-title":"Structural insights into the transcription-independent apoptotic pathway of p53","volume":"47","author":"Chi","year":"2014","journal-title":"BMB Rep."},{"issue":"1","key":"10.1016\/j.intimp.2022.109656_b0180","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1186\/s12882-019-1383-1","article-title":"Angiopoietin-like-3 knockout protects against glomerulosclerosis in murine adriamycin-induced nephropathy by attenuating podocyte loss","volume":"20","author":"Dai","year":"2019","journal-title":"BMC Nephrol."},{"key":"10.1016\/j.intimp.2022.109656_b0185","doi-asserted-by":"crossref","DOI":"10.1155\/2013\/135608","article-title":"Angiopoietin-like 3 induces podocyte F-actin rearrangement through integrin \u03b1(V)\u03b23\/FAK\/PI3K pathway-mediated Rac1 activation","author":"Lin","year":"2013","journal-title":"BioMed. Res. Int."},{"issue":"1","key":"10.1016\/j.intimp.2022.109656_b0190","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1007\/s00441-011-1181-y","article-title":"TGF-\u03b21 \u2192 SMAD\/p53\/USF2 \u2192 PAI-1 transcriptional axis in ureteral obstruction-induced renal fibrosis [J]","volume":"347","author":"Samarakoon","year":"2012","journal-title":"Cell Tissue Res."},{"key":"10.1016\/j.intimp.2022.109656_b0195","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/j.addr.2017.12.019","article-title":"Targeting renal fibrosis: Mechanisms and drug delivery systems","volume":"129","author":"Nastase","year":"2018","journal-title":"Adv Drug Deliv Rev"},{"key":"10.1016\/j.intimp.2022.109656_b0200","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.ejphar.2017.12.016","article-title":"Inflammation and renal fibrosis: Recent developments on key signaling molecules as potential therapeutic targets [J]","volume":"820","author":"Lv","year":"2018","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.intimp.2022.109656_b0205","article-title":"Mito-TEMPO Alleviates Renal Fibrosis by Reducing Inflammation Mitochondrial Dysfunction, and Endoplasmic Reticulum Stress","author":"Liu","year":"2018","journal-title":"Oxidative medicine and cellular longevity"},{"issue":"1","key":"10.1016\/j.intimp.2022.109656_b0210","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1152\/physrev.00020.2002","article-title":"Cell biology of the glomerular podocyte","volume":"83","author":"PAVENST\u00e4DT","year":"2003","journal-title":"Physiol. Rev."},{"issue":"1","key":"10.1016\/j.intimp.2022.109656_b0215","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1038\/s41572-020-0196-7","article-title":"Podocytopathies","volume":"6","author":"Kopp","year":"2020","journal-title":"Nat. Rev. Dis. Primers"},{"issue":"4","key":"10.1016\/j.intimp.2022.109656_b0220","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1038\/s41580-019-0110-x","article-title":"The multiple mechanisms that regulate p53 activity and cell fate","volume":"20","author":"Hafner","year":"2019","journal-title":"Nat. Rev. Mol. Cell Biol."},{"issue":"3","key":"10.1016\/j.intimp.2022.109656_b0225","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1681\/ASN.2021101293","article-title":"Mechanisms and models of kidney tubular necrosis and nephron loss","volume":"33","author":"Maremonti","year":"2022","journal-title":"J. Am. Soc. Nephrol. JASN"}],"container-title":["International Immunopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576922011419?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576922011419?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,1,9]],"date-time":"2025-01-09T14:07:35Z","timestamp":1736431655000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1567576922011419"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2]]},"references-count":45,"alternative-id":["S1567576922011419"],"URL":"https:\/\/doi.org\/10.1016\/j.intimp.2022.109656","relation":{},"ISSN":["1567-5769"],"issn-type":[{"value":"1567-5769","type":"print"}],"subject":[],"published":{"date-parts":[[2023,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Minnelide combined with Angptl3 knockout completely protects mice with adriamycin nephropathy via suppression of TGF-\u03b21-Smad2 and p53 pathways","name":"articletitle","label":"Article Title"},{"value":"International Immunopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.intimp.2022.109656","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Author(s). Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"109656"}}